Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Dallas › NPI 1629454053
Lab

Reliance Medlabs

Reliance Medlabs was paid $202K by Medicaid between Jan 2018 and Nov 2024, across 95 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 13% of everything it billed.

33Billing provider infoRELIANCE MEDLABS
DALLAS, TX 75252
33aNPI1629454053assigned 08/07/2015
28Total paid$202K
24GClaims283,511
24DCodes billed95
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#122 of 436
Median peer was paid$17K
This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201819,944$9K
20199,290$0.00
202025,915$7K
202156,125$23K
202268,927$50K
202359,458$48K
2024incomplete43,852$65K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 13% 13,644 13,409 $26K
80061 Lipid panel 7.4% 17,214 16,910 $15K
83880 5.9% 2,058 2,008 $12K
80053 Comprehensive metabolic panel 5.1% 21,453 20,139 $10K
80050 General health panel 5.0% 617 614 $10K
82607 5.0% 8,647 8,511 $10K
83036 Hemoglobin; glycosylated (A1C) 4.9% 17,438 17,115 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4.3% 1,056 1,014 $9K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4.1% 22,434 21,003 $8K
84443 Thyroid stimulating hormone (TSH) 4.0% 15,143 14,839 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 3.8% 1,766 1,628 $8K
82746 3.2% 4,835 4,765 $7K
83 more codes
99204 Doctor's office visit, new patient (more involved) 3.0% 79 $6K
84480 2.9% 4,876 $6K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 2.5% 1,703 $5K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.4% 1,007 $5K
86710 2.4% 1,094 $5K
87150 2.1% 1,716 $4K
87581 1.5% 1,096 $3K
87486 1.5% 1,096 $3K
87631 1.4% 1,095 $3K
87500 1.3% 1,615 $3K
84479 1.3% 5,877 $3K
87641 1.0% 1,640 $2K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 449 $2K
99214 Doctor's office visit, returning patient (more involved) <1% 35 $2K
83721 <1% 6,802 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,615 $2K
81002 <1% 5,191 $2K
84153 <1% 2,398 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 708 $1K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 826 $1K
83970 <1% 719 $1K
81001 <1% 5,840 $1K
87640 <1% 1,640 $898.10
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source <1% 419 $887.04
83735 <1% 2,806 $750.52
99203 Doctor's office visit, new patient (routine) <1% 17 $627.48
84550 <1% 2,739 $428.02
83550 <1% 1,596 $371.99
86140 <1% 1,449 $371.86
83540 <1% 1,656 $348.64
84439 <1% 1,995 $338.89
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 31 $309.54
82728 <1% 1,274 $284.53
84100 <1% 564 $259.20
87088 <1% 1,167 $253.25
80048 Basic metabolic panel (calcium, ionized) <1% 2,036 $239.37
85651 <1% 752 $178.08
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 27,846 $172.25
82043 <1% 1,443 $165.68
87086 Culture, bacterial; quantitative colony count, urine <1% 255 $137.35
82550 <1% 1,249 $124.24
80069 <1% 791 $116.27
82570 <1% 958 $54.55
82310 <1% 312 $40.24
83090 <1% 32 $37.65
85611 <1% 133 $33.56
85610 <1% 136 $32.40
82565 <1% 282 $28.93
82374 <1% 288 $27.50
82040 <1% 468 $26.34
87522 Neg quan hep c or qual rna <1% 14 $18.00
80164 <1% 15 $17.07
86430 <1% 27 $12.90
86803 <1% 45 $12.00
86431 <1% 86 $11.90
84403 <1% 17 $10.84
86708 <1% 42 $10.42
86704 <1% 42 $10.12
86706 <1% 42 $9.02
87340 <1% 42 $8.68
84481 <1% 105 $7.12
84460 <1% 373 $7.06
84075 <1% 364 $6.91
84450 <1% 345 $6.91
82533 <1% 12 $6.85
82247 <1% 350 $6.69
84155 <1% 369 $6.42
86592 <1% 12 $3.60
84156 <1% 55 $3.13
81015 <1% 155 $2.60
85045 <1% 59 $1.68
36415 Collection of venous blood by venipuncture <1% 38,305 $1.40
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 0% 1,096 $0.00
83921 0% 25 $0.00
99000 0% 161 $0.00
85652 0% 13 $0.00
83722 0% 56 $0.00
83520 0% 25 $0.00
80076 0% 1,230 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 0% 11,850 $0.00
84146 0% 27 $0.00
85007 0% 17 $0.00
82465 0% 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFAZAL, IRFAN (OWNER, PRESIDENT)